Zuo, Qiang <br/><br/>
The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Jun 2011 
 - 168-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2011.02.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma<br/>Cell Line, Tumor<br/>Cetuximab<br/>Drug Resistance, Neoplasm<br/>Humans<br/>JNK Mitogen-Activated Protein Kinases--biosynthesis<br/>Mitogen-Activated Protein Kinase 1--biosynthesis<br/>Mitogen-Activated Protein Kinase 3--biosynthesis<br/>NF-kappa B--biosynthesis<br/>Nasopharyngeal Carcinoma<br/>Nasopharyngeal Neoplasms--drug therapy<br/>Nucleoproteins--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Proto-Oncogene Proteins c-fos--biosynthesis<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>RNA, Small Interfering--administration & dosage<br/>Signal Transduction--drug effects<br/>Transfection<br/>p38 Mitogen-Activated Protein Kinases--genetics